No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial

The aim of this study was to evaluate the clinical effects of dexamethasone administration in patients with mild to moderate acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19). The study included 50 patients who were randomly assigned to the dexamethasone group or...

Descripción completa

Detalles Bibliográficos
Autores principales: Jamaati, Hamidreza, Hashemian, Seyed MohammadReza, Farzanegan, Behrooz, Malekmohammad, Majid, Tabarsi, Payam, Marjani, Majid, Moniri, Afshin, Abtahian, Zahra, Haseli, Sara, Mortaz, Esmaeil, Dastan, Alireza, Mohamadnia, Abdolreza, Vahedi, Abdolbaset, Monjazebi, Fatemeh, Yassari, Fatemeh, Fadaeizadeh, Lida, Saffaei, Ali, Dastan, Farzaneh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885705/
https://www.ncbi.nlm.nih.gov/pubmed/33607104
http://dx.doi.org/10.1016/j.ejphar.2021.173947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885705/
https://www.ncbi.nlm.nih.gov/pubmed/33607104
http://dx.doi.org/10.1016/j.ejphar.2021.173947

Ejemplares similares